Browsing Tag
Robert Montgomery
1 post
Imlifidase clears pivotal US Phase 3 trial with strong kidney transplant results as Hansa Biopharma eyes FDA filing
Hansa Biopharma’s Imlifidase meets its Phase 3 trial endpoint in US kidney transplantation, setting up FDA filing and reshaping biotech investor sentiment.